当前位置:首页 - 行情中心 - 葵花药业(002737) - 财务分析 - 现金流量表

葵花药业

(002737)

  

流通市值:69.20亿  总市值:69.20亿
流通股本:5.84亿   总股本:5.84亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,369,572,816.321,606,402,625.95846,012,773.563,088,389,815.96
  收到其他与经营活动有关的现金48,970,448.5530,236,567.8513,581,283.77158,909,945.72
  经营活动现金流入小计2,418,543,264.871,636,639,193.8859,594,057.333,247,299,761.68
  购买商品、接受劳务支付的现金776,878,868.55563,385,696.6255,078,756.68842,071,176.85
  支付给职工以及为职工支付的现金455,984,339.4313,266,254.03145,994,897.4563,392,758.43
  支付的各项税费216,772,344.3140,384,186.8489,216,013.33232,575,591.01
  支付其他与经营活动有关的现金887,300,258.8594,055,086.02291,197,550.021,034,294,625.04
  经营活动现金流出小计2,336,935,811.051,611,091,223.49781,487,217.432,672,334,151.33
  经营活动产生的现金流量净额81,607,453.8225,547,970.3178,106,839.9574,965,610.35
二、投资活动产生的现金流量:
  收回投资收到的现金6,958,414,0154,758,414,0152,358,414,0159,317,544,011
  取得投资收益收到的现金23,800,034.1518,525,953.3211,469,388.6135,480,586.76
  处置固定资产、无形资产和其他长期资产收回的现金净额183,052137,70040,000524,714
  投资活动现金流入小计6,982,397,101.154,777,077,668.322,369,923,403.619,353,549,311.76
  购建固定资产、无形资产和其他长期资产支付的现金76,849,505.1451,349,478.2327,209,732.2396,103,588.21
  投资支付的现金6,680,390,0004,280,000,0001,800,000,0009,810,001,000
  支付其他与投资活动有关的现金---62,937.89
  投资活动现金流出小计6,757,239,505.144,331,349,478.231,827,209,732.239,906,167,526.1
  投资活动产生的现金流量净额225,157,596.01445,728,190.09542,713,671.38-552,618,214.34
三、筹资活动产生的现金流量:
  取得借款收到的现金83,000,00075,000,000-118,000,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计83,000,00075,000,000-118,000,000
  偿还债务支付的现金5,000,000--13,000,000
  分配股利、利润或偿付利息支付的现金127,693,808.66-603,750311,071,734.72
  其中:子公司支付给少数股东的股利、利润10,893,808.66--18,947,768.05
  支付其他与筹资活动有关的现金2,203,992.172,203,522.781,783,556.124,122,924.06
  筹资活动现金流出小计134,897,800.832,203,522.782,387,306.12328,194,658.78
  筹资活动产生的现金流量净额-51,897,800.8372,796,477.22-2,387,306.12-210,194,658.78
四、汇率变动对现金及现金等价物的影响-438,917.82-327,085.64-175,358.63-193,176.66
五、现金及现金等价物净增加额254,428,331.18543,745,551.98618,257,846.53-188,040,439.43
  加:期初现金及现金等价物余额849,920,259.08849,920,259.08849,920,259.081,037,960,698.51
  期末现金及现金等价物余额1,104,348,590.261,393,665,811.061,468,178,105.61849,920,259.08
补充资料:
  净利润-85,479,307.67--297,073,301.51
  资产减值准备-34,587,404.31-77,428,515.19
  固定资产和投资性房地产折旧-60,792,457-141,708,886.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-60,792,457-141,708,886.19
  无形资产摊销-13,149,223.22-26,615,432.56
  长期待摊费用摊销-2,234,892.04-4,434,304.92
  处置固定资产、无形资产和其他长期资产的损失-140,134.19-654,459.15
  固定资产报废损失---1,191,497.68
  公允价值变动损失-12,924,888.74--3,891,722.08
  财务费用-1,995,411.75-4,001,177.6
  投资损失--15,716,642.36--31,048,755.67
  递延所得税--149,043.57--28,463,731.21
  其中:递延所得税资产减少-650,187.36--26,523,568.09
    递延所得税负债增加--799,230.93--1,940,163.12
  存货的减少-4,703,781.62-229,946,642.24
  经营性应收项目的减少-32,814,077.89-421,485,281.38
  经营性应付项目的增加--209,874,693.87-23,144,120.09
  现金的期末余额-1,393,665,811.06-849,920,259.08
  减:现金的期初余额-849,920,259.08-1,037,960,698.51
  现金及现金等价物的净增加额-543,745,551.98--188,040,439.43
公告日期2026-10-302026-08-292026-04-302026-04-27
审计意见(境内)标准无保留意见
TOP↑